Genetics of diabetic nephropathy

Journal of the American Society of Nephrology

Volumn 7, Issue 12, 1996, Pages 2509-2517

  Parving, Hans Henrik ^a   Tarnow, Lise ^a   Rossing, Peter ^a  

^a STENO DIABETES CENTER   (Denmark)

Author keywords

Genes; IDDM; Nephropathy; NIDDM; Risk factors

Indexed keywords

ANGIOTENSIN 1 RECEPTOR; ANGIOTENSINOGEN; DIPEPTIDYL CARBOXYPEPTIDASE; DNA;

CARDIOVASCULAR DISEASE; DIABETIC NEPHROPATHY; GENETIC MARKER; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; HUMAN; HYPERTENSION; INSULIN DEPENDENT DIABETES MELLITUS; KIDNEY FAILURE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SODIUM TRANSPORT;

EID: 0030405835     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (95)

1. Kimmelstiel P, Wilson C: Intercapillary lesions in the glomeruli of the kidney. Am J Pathol 1936;12:83-96.
2. Deckert T, Parving H-H, Andersen AR, et al. Diabetic nephropathy: A clinical and morphometric study. In: Eschwege E, Ed. Advances in Diabetes Epidemiology. Amsterdam: Elsevier Biomedical Press; 1982:235-243.
3. Grenfell A, Bewick M, Parsons V, Snowden S, Taube D, Watkins PJ: Non-insulin-dependent diabetes and renal replacement therapy. Diabetic Med 1988;5:172-176.
4. Parving H-H, Gall M-A, Skøtt P, et al.: Prevalence and causes of albuminuria in non-insulin-dependent diabetic patients. Kidney Int 1992;41:758-762.
5. Parving H-H, Østerby R, Anderson PW, Hsueh WA. Diabetic nephropathy. In: Brenner BM, Ed. The Kidney, 5th Ed. Philadelphia: Saunders; 1996;1864-1892.
6. Krolewski AS, Warram JH: Genetic susceptibility to diabetic kidney disease: An update. J Diabetes Complications 1995;9:277-281.
7. Trevisan R, Viberti GC: Genetic predisposition and diabetic nephropathy. Diab Nutr Metab 1995;8:159-165.
8. Chowdhury TA, Kumar S, Barnett AH, Bain SC: Nephropathy in type 1 diabetes: The role of genetic factors. Diabetic Med 1995;12:1059-1067.
9. Nelson RG, Newman JM, Knowler WC, et al.: Incidence of end-stage renal disease in type 2 (non-insulin- dependent) diabetes mellitus in Pima Indians. Diabetologia 1988;31:730-736.
10. Ballard DJ, Humphrey LL, Melton LJ III, et al.: Epidemiology of persistent proteinuria in Type II diabetes mellitus. Population-based study in Rochester, Minnesota. Diabetes 1988;37:405-412.
11. Bojestig M, Arnqvist HJ, Hermansson G, Karlberg B, Ludvigsson J: Declining incidence of nephropathy in insulin-dependent diabetes mellitus. N Engl J Med 1994;330:15-18.
12. Rossing P, Rossing K, Jacobsen P, Parving H-H: Unchanged incidence of diabetic nephropathy in IDDM patients. Diabetes 1995;44:739-743.
13. Seaquist ER, Goetz FC, Rich S, Barbosa J: Familial clustering of diabetic kidney disease: Evidence of genetic susceptibility to diabetic nephropathy. N Engl J Med 1989:320:1161-1165.
14. Reeders ST: Genetic factors in diabetic nephropathy. N Engl J Med 1989;321:905.
15. McCance DR, Hanson RL, Pettitt DJ, Jacobsson LTH, Bennett PH, Bishop DT: Diabetic nephropathy: A risk factor for diabetes mellitus in offspring. Diabetologia 1995;38:221-226.
16. Borch-Johnsen K, Nørgaard K, Hommel E, et al.: Is diabetic nephropathy an inherited complication? Kidney Int 1992;41:719-722.
17. Quinn M, Angelico MC, Cross A, Gearin G, Warram JH: Concordance for kidney complications in siblings with IDDM [Abstract]. Diabetes 1992;41:121A.
18. Pettitt DJ, Saad MF, Bennett PH, Nelson RG, Knowler WC: Familial predisposition to renal disease in two generations of Pima Indians with type 2 (non-insulin- dependent) diabetes mellitus. Diabetologia 1990;33: 438-443.
19. Freedman BI, Tuttle AB, Spray BJ: Familial predisposition to nephropathy in African-Americans with non- insulin-dependent diabetes mellitus. Am J Kidney Dis 1995;25:710-713.
20. Cowie CC, Port FK, Wolfe RA, Savage PJ, Moll PP, Hawthorne VM: Disparities in incidence of diabetic end- stage renal disease according to race and type of diabetes. N Engl J Med 1989;321:1074-1079.
21. Earle K, Walker J, Hill C, Viberti GC: Familial clustering of cardiovascular disease in patients with insulin- dependent diabetes and nephropathy. N Engl J Med 1992;326:673-677.
22. Nørgaard K, Mathiesen ER, Hommel E, Jensen JS, Parving H-H: Lack of familial predisposition to cardiovascular disease in type 1 (insulin-dependent) diabetic patients with nephropathy. Diabetologia 1991;34:370-372.
23. Brenner BM, Chertow GM: Congenital oligonephropathy and the etiology of adult hypertension and progressive renal injury. Am J Kidney Dis 1994;23:171-175.
24. Barker DJP: Fetal origins of coronary heart disease. Br Med J 1995;311:171-174.
25. Rossing P, Tarnow L, Nielsen FS, Boelskifte S, Brenner BM, Parving H-H: Short stature and diabetic nephropathy. Br Med J 1995;310:296-297.
26. Gould MM, Mohamed-Ali V, Goubet SA, Yudkin JS, Haines AP: Microalbuminuria: Associations with height and sex in non-diabetic subjects. Br Med J 1993;306: 240-242.
27. Rossing P, Tarnow L, Nielsen FS, Hansen BV, Brenner BM, Parving H-H: Low birth weight: A risk factor for development of diabetic nephropathy? Diabetes 1995; 44:1405-1407.
28. Garrett PJ, Sandeman DD, Reza M, et al.: Weight at birth and renal disease in adulthood [Abstract]. Nephrol Dial Transplant 1993;8:920A.
29. Nielsen FS, Gall M-A, Parving H-H: Acquired oligonephropathy and diabetic nephropathy. Am J Kidney Dis 1995;26:898-903.
30. Viberti GC, Keen H, Wiseman MJ: Raised arterial pressure in parents of proteinuric insulin-dependent diabetics. Br Med J 1987;295:515-517.
31. Walker JD, Tariq T, Viberti GC: Sodium-lithium countertransport activity in red cells of patients with insulin- dependent diabetes and nephropathy and their parents. Br Med J 1990;301:635-638.
32. Jensen JS, Mathiesen ER, Nørgaard K, et al.: Increased blood pressure and erythrocyte sodium-lithium counter- transport activity are not inherited in diabetic nephropathy. Diabetologia 1990;33:619-624.
33. Krolewski AS, Canessa H, Warram JH, et al.: Predisposition to hypertension and susceptibility to renal disease in insulin-dependent diabetes mellitus. N Engl J Med 1988;318:140-145.
34. Barzilay J, Warram JH, Bak M, Laffel LMB, Canessa M, Krolewski AS: Predisposition to hypertension: Risk factor for nephropathy and hypertension in IDDM. Kidney Int 1992;41:723-730.
35. Molitch ME, Steffes MW, Cleary PA, Nathan DM: Baseline analysis of renal function in diabetes control and complications trial. Kidney Int 1993;43:668-674.
36. Watt G: Design and interpretation of studies comparing individuals with and without a family history of high blood pressure. J Hypertens 1986;4:1-17.
37. Parving H-H, Hommel E, Mathiesen ER, et al.: Prevalence of microalbuminuria, arterial hypertension, retinopathv and neuropathy in patients with insulin- dependent diabetes. Br Med J 1988;296:156-160.
38. Gall M-A, Rossing P, Skøtt P, et al.: Prevalence of micro- and macroalbuminuria, arterial hypertension, retinopathy and large vessel disease in European Type 2 (non- insulin-dependent) diabetic patients. Diabetologia 1991; 34:655-661.
39. Jameel N, Pugh JA: Presence of pre-existing hypertension is more important than ethnicity in determining duration of diabetes prior to ESRD in NIDDM [Abstract]. J Am Soc Nephrol 1991;2:291A.
40. Hilton PJ: Cellular sodium transport in essential hypertension. N Engl J Med 1986;314:222-229.
41. Beukelmann D, Erdmann E: Exogenous factors influencing the human erythrocyte sodium-lithium counter- transport system. Eur J Clin Invest 1984;14:392-397.
42. Rutherford PA, Thomas TH, Wilkinson R: Erythrocyte sodium-lithium countertransport: Clinically useful, pathophysiologically instructive or just phenomenology? Clin Sci 1992;82:341-352.
43. Boerwinkle E, Turner ST, Weinshiliboum R, Johnson M, Sing CF: Analysis of the distribution of erythrocyte sodium-lithium countertransport in a sample representative of the general population. Genet Epidemiol 1986; 3:365-378.
44. Crompton CH, Balfe JW, Balfe JA, Chatzillias A, Daneman D: Sodium-lithium transport in adolescents with IDDM. Diabetes Care 1994;17:704-710.
45. Hardman TC, Dubrey SW, Leslie DG, Hafiz M, Noble MI, Lant AF: Erythrocyte sodium-lithium countertransport and blood pressure in identical twin pairs discordant for insulin dependent diabetes. Br Med J 1992;305:215-219.
46. Cambien F, Poirier O, Lecerf L, et al.: Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarction. Nature (Lond) 1992;359:641-644.
47. Tarnow L, Cambien F, Rossing P, et al.: Lack of relationship between an insertion/deletion polymorphism in the angiotensin-I-converting enzyme gene and diabetic nephropathy and proliferative retinopathy in IDDM patients. Diabetes 1995;44:489-494.
48. Marre M, Bernadet P, Gallois Y, et al.: Relationships between angiotensin I converting enzyme gene polymorphism, plasma levels, and diabetic retinal and renal complications. Diabetes 1994;43:384-388.
49. Schmidt S, Schöne N, Ritz E: The diabetic nephropathy study group: Association of ACE gene polymorphism and diabetic nephropathy? Kidney Int 1995;47:1176-1181.
50. Tarnow L, Cambien F, Rossing P, et al.: Angiotensin II type 1 receptor gene polymorphism and diabetic microangiopathy. Nephrol Dial Transplant 1996;11:1019-1023.
51. Doria A, Gearin G, Onuma T, Warram JH, Krolewski AS: Synergistic effect of angiotensin-II type 1 receptor (AT1T) genotype and poor glycemic control on risk of nephropathy in IDDM [Abstract]. Diabetes 1995;44:23A.
52. Jacobsen P, Tarnow L, Rossing P, et al.: The insertion/ deletion (I/D) polymorphism in the angiotensin-I- converting enzyme (ACE) gene predicts the progression of diabetic nephropathy during ACE inhibition (ACEI) in insulin dependent diabetic (IDDM) patients [Abstract]. J Am Soc Nephrol 1995;6:450A.
53. Yoshida H, Hamaguchi A, Mitarai T, et al.: Accelerated progression to renal failure in NIDDM patients with the deletion polymorphism of the angiotensin converting enzyme (ACE) gene [Abstract]. J Am Soc Nephrol 1995; 6:409.
54. Mathiesen ER, Rønn B, Jensen T, Storm B, Deckert T: Relationship between blood pressure and urinary albumin excretion in development of microalbuminuria. Diabetes 1990;39:245-249.
55. Rudberg S, Persson B, Dahlquist G: Increased glomerular filtration rate as a predictor of diabetic nephropathy: An 8-year prospective study. Kidney Int 1992;41: 822-828.
56. Microalbuminuria Collaborative Study Group UK: Risk factors for development of microalbuminuria in insulin dependent diabetic patients: A cohort study. Br Med J 1993;306:1235-1239.
57. The Diabetes Control and Complications Trial Research Group: Effect of intensive therapy on the development and progression of diabetic nephropathy in the diabetes control and complications trial. Kidney Int 1995;47:1703-1720.
58. Klein R, Klein BEK, Moss SE, Cruickshanks KJ: Ten- year incidence of gross proteinuria in people with diabetes. Diabetes 1995;44:916-923.
59. Nelson RG, Pettitt DJ, Baird HR, et al.: Pre-diabetic blood pressure predicts urinary albumin excretion after the onsel of type 2 (non-insulin-dependent) diabetes mellitus in Pima Indians. Diabetologia 1993; 36:998- 1001.
60. Mangili R, Bending JJ, Scott GS, Lai LK, Gupta A, Viberti GC: Increased sodium-lithium counter transport activity in red cells of patients with insulin dependent diabetes and nephropathy. N Engl J Med 1988;318:146-150.
61. Elving LD, Wetzels JFM, de Nobel E, Berden JHM: Erythrocyte sodium-lithium countertransport is not different in type 1 (insulin-dependent) diabetic patients with and without diabetic nephropathy. Diabetologia 1991;34:126-128.
62. Mangili R, Zerbini G, Barlassina C, Cusi D, Pozza G: Sodium-lithium countertransport and triglycerides in diabetic nephropathy. Kidney Int 1993;44:127-133.
63. Dowd A, Thomas TH, Taylor R, Wilkinson R: Erythrocyte sodium-lithium countertransport activity is related to membrane fluidity in IDDM patients. Diabetologia 1994;37:394-400.
64. Gall M-A, Rossing P, Jensen JS, Funder J, Parving H-H: Red cell Na/Li countertransport in non-insulin- dependent diabetics with diabetic nephropathy. Kidney Int 1991;39:135-140.
65. Fujita J, Tsuda K, Seno M, Obayashi H, Fukui I, Seino Y: Erythrocyte sodium-lithium countertransport activity as a marker of predisposition to hypertension and diabetic nephropathy in NIDDM. Diabetes Care 1994;17:977-982.
66. Pinkney JH, Foyle W-J, Denver AE, Mohamed-Ali V, McKinlay S, Yudkin JS: The relationship to urinary albumin excretion rate to ambulatory blood pressure and erythrocyte sodium-lithium countertransport in NIDDM. Diabetologia 1995;38:356-362.
67. Kawagishi T, Nishizawa Y, Hosoi M, et al.: Relationship between ACE gene and carotid or femoral atherosclerosis in IDDM patients [Abstract]. Diabetologia 1995;38:A227.
68. Rasmussen LM, Ledet T: Atherosclerosis in diabetes is associated with the I/D-polymorphism in the angiotensin I-converting enzyme gene [Abstract]. Diabetologia 1995;3:A228.
69. Tarnow L, Cambien F, Rossing P, et al.: Insertion/ deletion polymorphism in the angiotensin-I-converting enzyme gene is associated with coronary heart disease in IDDM patients with diabetic nephropathy. Diabetologia 1995;38:798-803.
70. Chaturvedi N, Talmud P, Fuller JH: Angiotensin converting enzyme (ACE) gene polymorphisms and complications in insulin dependent diabetes mellitus (IDDM) [Abstract], Diabetologia 1995;38:A227.
71. Ruiz J, Blanché H, Cohen N, et al.: Insertion/deletion polymorphism of the angiotensin-converting enzyme gene is strongly associated with coronary heart disease in non-insulin-dependent diabetes mellitus. Proc Natl Acad Sci USA 1994;91:3662-3665.
72. Keavney BD, Dudley CRK, Stratton IM, et al.: UK prospective diabetes study (UKPDS) 14: Association of angiotensin-converting enzyme insertion/deletion polymorphism with myocardial infarction in NIDDM. Diabetologia 1995;38:948-952.
73. Fujisawa T, Ikegami H, Shen G-Q, et al.: Angiotensin I-converting enzyme gene polymorphism is associated with myocardial infarction, but not with retinopathy or nephropathy, in NIDDM. Diabetes Care 1995;18:983-985.
74. Ukkola O, Savolainen MJ, Salmela PI, von Dickhoff K, Kiem T, Kesäniemi YA: Insertion/deletion polymorphism in the angiotensin-converting enzyme gene associated with macroangiopathy and blood pressure in patients with non-insulin-dependent diabetes mellitus. J Mol Med 1995;73:307-311.
75. Doria A, Warram JH, Krolewski AS: Genetic predisposition to diabetic nephropathy: Evidence for a role of the Angiotensin I-converting enzyme gene. Diabetes 1994; 43:690-695.
76. Fogarty DG, Hughes AE, Nevin NC, Doherty CC, Maxwell AP: Functional genetic markers of the renin-angiotensin system and the risk of diabetic nephropathy (DN) in insulin-dependent diabetes mellitus (IDDM) [Abstract]. J Am Soc Nephrol 1994;5:376A.
77. Powrie JK, Watts GF, Ingham JN, Taub NA, Talmud PJ, Shaw KM: Role of glycaemic control in development of microalbuminuria in patients with insulin dependent diabetes. Br Med J 1994;309:1608-1612.
78. Rabensteiner D, Mayer G, Abrahamian H, et al.: Relationship between angiotensin-I-converting enzyme polymorphism and microangiopathy in IDDM subjects [Abstract]. Diabetologia 1995;38:A227.
79. Hibberd ML, Millward BA, Demaine AG: Angiotensin converting enzyme genotypes and complications in type 1 diabetes [Abstract]. Diabetologia 1995;38:A227.
80. Bilo HJG, Thijssen S, de Knijff P, Stehouwer CDA, Kluft C: ACE and ANG gene polymorphism and diabetic nephropathy [Abstract]. J Am Soc Nephrol 1995;6:1037A.
81. Jagger C, Kilpatrick ES, Small M, Spooner RJ: Angiotensin converting enzyme I/D polymorphism may not be associated with diabetic disease [Abstract]. Diabetic Med 1995;12[Suppl 2]:S50.
82. Mizuiri S, Hemmi H, Inoue A, et al.: Angiotensin- converting enzyme polymorphism and development of diabetic nephropathy in non-insulin-dependent diabetes mellitus. Nephron 1995;70:455-459.
83. Dudley CRK, Keavney BD, Stratton IM, Turner RC, Ratcliffe PJ: U.K. Prospective Diabetes Study XV: Relationship of renin-angiotensin system gene polymorphisms with microalbuminuria in NIDDM. Kidney Int 1995;48:1907-1911.
84. Doi Y, Yoshizumi H, Yoshinari M, et al.: Association between a polymorphism in the angiotensin-converting enzyme gene and microvascular complications in Japanese patients with NIDDM. Diabetologia 1996;39:97-102.
85. Tarnow L, Cambien F, Rossing P, et al.: Angiotensinogen gene polymorphisms in IDDM patients with diabetic nephropathy. Diabetes 1996;45:367-369.
86. Fogarty DG, Harron JC, Hughes AE, Doherty CC, Maxwell AP: The association of an angiotensinogen gene variant with diabetic nephropathy [Abstract]. J Am Soc Nephrol 1995;6:449A.
87. Schmidt S, Strojek K, Grzeszczak W, Ganten D, Ritz E: The M235T variant of the angiotensinogen gene and nephropathy in type 2 diabetes [Abstract]. J Am Soc Nephrol 1995;6:1047A.
88. McLaughlin KJ, Jagger C, Small M, Jardine AG: Effect of angiotensinogen gene T235 variant on the development of diabetic complications in type II diabetes mellitus. Lancet 1995;346:1160.
89. Harden PN, Geddes C, Rowe PA, et al.: Polymorphisms in angiotensin-converting-enzyme gene and progression of IgA nephropathy. Lancet 1995;345:1540-1542.
90. Gaciong Z, Religa P, Placha G, et al.: High frequency of D allele of angiotensin-converting enzyme (ACE) among renal allograft recipients [Abstract]. J Am Soc Nephrol 1995;6:721A.
91. Yoshida H, Mitarai T, Kawamura T, et al.: Role of the deletion polymorphism of the angioterisin converting enzyme gene in the progression and therapeutic responsiveness of IgA nephropathy. J Clin Invest 1995;96: 2162-2169.
92. Harden PN, Geddes C, Rowe PA, et al.: ACE gene polymorphism and progression of renal disease [Abstract]. J Am Soc Nephrol 1995;6:390A.
93. Ogura M, Yoshida H, Kawamura T, et al.: The impact of the ACE gene polymorphism on the slowly progressive IgA nephropathy may be linked to the glomerular size [Abstract]. J Am Soc Nephrol 1995;6:3A.
94. van Essen GG, Rensma PL, de Zeeuw D, et al.: Association between angiotensin-converting-enzyme gene polymorphism and failure of renoprotective therapy. Lancet 1996;347:94-95.
95. Hunley TE, Julian BA, Philips JA, et al.: Polymorphism of angiotensin converting enzyme (ACE), but not angiotensinogen (Agt) or angiotensin type 1 receptor (AT1) genes predicts progressive renal damage in IgA nephropathy [Abstract]. J Am Soc Nephrol 1995;6:391A.